Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 70

Combining statins with amlodipine to treat primary aldosteronism

Official title: A Prospective, Multi-center, Randomized Trial to Compare Statin Combined with CCB to MRA Combined with CCB in Primary Aldosteronism Treatment

Run by Third Military Medical University · NCT06523465 · Data updated 2026-11-12

This study is testing if combining statins with amlodipine can help people with primary aldosteronism manage their condition better.

More Hypertension trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment180 (estimated)
SponsorThird Military Medical University
Academic / other
Locations1 site (Chongqing, Chongqing Municipality)
StatusRecruiting
StartedSeptember 10, 2024
Main results expectedDecember 30, 2025
Study endsSeptember 30, 2026
Registry record updatedNovember 22, 2024
Trial IDNCT06523465 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with primary aldosteronism.

Probably not a fit

Patients with allergies to the study drugs, pregnancy, severe liver or kidney dysfunction, or mental illness may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of combining statins with amlodipine in treating patients with primary aldosteronism. Participants will be randomly assigned to one of three treatment groups: one receiving statin and amlodipine, another receiving statin, spironolactone, and amlodipine, and the last receiving amlodipine and spironolactone. The study will monitor changes in plasma aldosterone levels, 24-hour urinary aldosterone, blood pressure, and long-term cardiovascular risks associated with these treatments.

Why it matters

Potential benefit: If successful, this study could improve treatment options and cardiovascular outcomes for patients with primary aldosteronism.

How similar studies have gone: While there is limited information on similar studies, the combination of these medications has shown promise in managing hypertension and related conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of primary aldosteronism

Exclusion Criteria:

* Allergy to drugs in this study
* Pregnancy
* Severe liver and kidney dysfunction
* Mental illness

Where it's running

  • No. 10 Changjiang River Branch, Yuzhong District,Chongqing, China
    Chongqing, Chongqing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Spironolactone with antihypertensives for unilateral primary aldosteronism

    This project will try different doses of spironolactone together with usual blood-pressure medicines in adults with lateralized primary aldosteronism who decline surgery to see if it relieves renin suppression and lowers long-term cardiovascular risks.

    Recruiting Third Military Medical University · Chongqing, Chongqing Municipality · NCT07137364

  • Screening for Primary Aldosteronism using Steroids

    This study is testing a new steroid-based method to see if it can better identify Primary Aldosteronism in people with high blood pressure who are taking their usual medications.

    Recruiting Chongqing Medical University · Chongqing, Chongqing Municipality · NCT06941116

  • Improving screening for primary aldosteronism in patients with hypertension

    This study is testing if giving a small dose of dexamethasone can help doctors better identify primary aldosteronism in patients with high blood pressure who are already on medication.

    Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT06740838

  • Quantifying sodium levels in muscles of patients with primary aldosteronism

    This study is testing a new way to measure sodium levels in the muscles of people with primary aldosteronism to see if it helps improve understanding and treatment of the condition.

    Recruiting at 2 sites Duke-NUS Graduate Medical School · Singapore and 3 other locations · NCT06569589

  • Using low-dose aspirin after preeclampsia to improve recovery

    This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

    Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

  • Impact of Aldosterone Blockade on Heart Function in Primary Aldosteronism

    This study is testing if a medication that blocks a hormone called aldosterone can improve heart function in people with primary aldosteronism, which causes high blood pressure.

    Recruiting Phase 4 Brigham and Women's Hospital · Boston, Massachusetts · NCT05030545

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.